That is what I think will eventually happen. Takeda will give AFFY shareholders a certain number of shares for Takeda shares, which will really suck because we won't get what we should get as an independent company instead of a company on its knees begging for loose change. I really hope it doesn't happen, but it's in the back of my mind.
You see low ball offers all the time. You see them get turned down and the offering company then upping its bid for your shares. You also see competitors come in if the property's really valuable and they can get a decent return for what they're offering. And so on. Don't be afraid of any offer takeda makes, if it makes one. Take it as a very good sign. Then make up your mind what you want to happen to your shares and vote accordingly. One other good thing. A buyout would remove a layer of useless mgt expense and a prospective buyer and competition will figure that in, normally making the stock even more valuable to them. First though, the drug has to be found worth buying up. Worry about the other later. First things first.
No company ever wants to buy AFFY with all the litigation that goes along with it. The smart move is to just wait and let time take its course. AFFY goes BK and then a purchaser can acquire whatever asset AFFY may have, at a bankruptcy court approved price which forecloses any and all challenges of fairness or adequacy of consideration, and without the headaches and litigation liabilities inherent in AFFY' securiities class action/products liabilities claims.
If there was a any sample situation in the past,like shell company holding a patent for drug and buyout...DO you guys remember anything like that? I mean this is very rare case,seriously I couldn't think anymore...